KOSDAQ · Healthcare · ₩3T
₩145,100-1.09%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 10.0% · as of 26.09.11
Among 15 신약 개발 peers
“글로벌 임상 진전으로 신약 후보의 가치가 커지고 있어요.”
In the company's words · 2026 2분기 filing